PL394514A1 - Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystosci elektroforetycznej z materialów biologicznych - Google Patents

Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystosci elektroforetycznej z materialów biologicznych

Info

Publication number
PL394514A1
PL394514A1 PL394514A PL39451411A PL394514A1 PL 394514 A1 PL394514 A1 PL 394514A1 PL 394514 A PL394514 A PL 394514A PL 39451411 A PL39451411 A PL 39451411A PL 394514 A1 PL394514 A1 PL 394514A1
Authority
PL
Poland
Prior art keywords
cysteine
preparation
biological materials
peptidase inhibitors
electrophoretic purity
Prior art date
Application number
PL394514A
Other languages
English (en)
Other versions
PL221015B1 (pl
Inventor
Maciej Siewinski
Jan Czarnecki
Stanisław Jujeczka
Justyna Seliga
Aleksander Zuchowski
Original Assignee
Akademia Medyczna Im. Piastów Slaskich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademia Medyczna Im. Piastów Slaskich filed Critical Akademia Medyczna Im. Piastów Slaskich
Priority to PL394514A priority Critical patent/PL221015B1/pl
Priority to EP12163789.6A priority patent/EP2511288B1/en
Publication of PL394514A1 publication Critical patent/PL394514A1/pl
Publication of PL221015B1 publication Critical patent/PL221015B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL394514A 2011-04-11 2011-04-11 Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystości elektroforetycznej z materiałów biologicznych PL221015B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL394514A PL221015B1 (pl) 2011-04-11 2011-04-11 Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystości elektroforetycznej z materiałów biologicznych
EP12163789.6A EP2511288B1 (en) 2011-04-11 2012-04-11 Method of obtaining inhibitors of cysteine peptidases with an electrophoretic purity from biological materials

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL394514A PL221015B1 (pl) 2011-04-11 2011-04-11 Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystości elektroforetycznej z materiałów biologicznych

Publications (2)

Publication Number Publication Date
PL394514A1 true PL394514A1 (pl) 2012-10-22
PL221015B1 PL221015B1 (pl) 2016-02-29

Family

ID=46085772

Family Applications (1)

Application Number Title Priority Date Filing Date
PL394514A PL221015B1 (pl) 2011-04-11 2011-04-11 Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystości elektroforetycznej z materiałów biologicznych

Country Status (2)

Country Link
EP (1) EP2511288B1 (pl)
PL (1) PL221015B1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220119496A1 (en) * 2019-02-15 2022-04-21 Andrzej Marek RAPAK Inhibitors of cysteine peptidases isolated from natural raw materials and use of the inhibitors in medicine and veterinary medicine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43397B (en) * 1985-01-16 1989-06-30 Inst Jozef Stefan Process for insulation of poultry eggs cystatine from egg-white
PL288769A1 (en) 1991-01-17 1992-08-10 Alfred Skrzypek Staircase lighting switch arrangement
US6193969B1 (en) * 1993-06-03 2001-02-27 Protherics Inc. Antibody fragments in therapy
PL174636B1 (pl) 1994-06-21 1998-08-31 Akad Medyczna Sposób otrzymywania inhibitorów cysteinowych peptydaz
PL190404B1 (pl) 1999-08-02 2005-12-30 Akad Medyczna Środek farmaceutyczny działający przeciwko nowotworom, mikroorganizmom chorobotwórczym i chorobom inwazyjnym

Also Published As

Publication number Publication date
EP2511288B1 (en) 2016-03-02
PL221015B1 (pl) 2016-02-29
EP2511288A1 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
ZA201305971B (en) Method for the purification of biphephos
EP2618154A4 (en) METHOD OF DETERMINING THE EFFICACY OF A MEDICAMENT CONTAINING ANTIBODY AS COMPONENT
EP2673380A4 (en) ANALYSIS OF NUCLEIC ACIDS
ZA201305972B (en) Method for the preparation of biphephos
IL227581B (en) A method for constructing certain coefficients
PT2573060T (pt) Método para alterar as propriedades de translucidez de materiais dentários de zircónio
EP2736905A4 (en) INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF LURASIDONE AND SALTS THEREOF
IL224318B (en) A method for the automated synthesis of small molecules
SG11201400939YA (en) Process for the preparation of methoxymelonal
EP2686660A4 (en) ARRANGEMENT FOR STORING BIOLOGICAL SAMPLES
HK1194733A1 (zh) 製備 -酰基- -苯基磺酰基脯氨酰胺衍生物的方法及中間體
EP2786130A4 (en) TECHNIQUES FOR QUANTIFICATION OF SAMPLES
IL236302A0 (en) Intermediates in the formation of ergatroben monohydrate
IL232735A0 (en) A process for purifying polyaminocarboxylates
ZA201303467B (en) Method for the preparation of high-purity pharmaceutical intermediates
EP2726652A4 (en) PROCESS FOR PROTEIN DISPLAY
RS55248B1 (sr) Postupak za biološku kontrolu listeria
SG11201401540WA (en) Method for synthesizing proteins
GB201119690D0 (en) Process for the preparation of compounds
PL394514A1 (pl) Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystosci elektroforetycznej z materialów biologicznych
PL393916A1 (pl) Sposób wytwarzania związków karbapenamowych
ZA201309732B (en) Process for the preparation of dexlansoprazole
EP2732262A4 (en) PROCESS FOR STABILIZING LIQUID BIOLOGICAL SAMPLES
HK1197229A1 (en) Process for the preparation of protease inhibitors
IL229920A (en) Intermediate Compounds and Method for Preparing Loracidone and its Salts